نتایج جستجو برای: pa and complex t

تعداد نتایج: 17043426  

Journal: :Blood 1988
D Collen J M Stassen G Larsen

The following mutants of human tissue-type plasminogen activator (t-PA) were constructed by deletion mutagenesis of t-PA cDNA, expressed in Chinese hamster ovary cells and purified to homogeneity: (a) t-PA-delta FE:t-PA lacking both the fibronectin fingerlike (F) domain and the epidermal growth factor (E) domain, (b) t-PA-delta FE1X:t-PA-delta FE with the glycosylated 117Asn mutagenized to Gln,...

2012
Agnese Ozolina Eva Strike Inta Jaunalksne Angelika Krumina Lars J Bjertnaes Indulis Vanags

UNLABELLED BACKGROUND Enhanced bleeding remains a serious problem after cardiac surgery, and fibrinolysis is often involved. We speculate that lower plasma concentrations of plasminogen activator inhibitor - 1 (PAI-1) preoperatively and tissue plasminogen activator/PAI-1 (t-PA/PAI-1) complex postoperatively might predispose for enhanced fibrinolysis and increased postoperative bleeding. ME...

ژورنال: :پژوهش های آسیب شناسی زیستی 0
azam rahimpour department of medical biotechnology, biotechnology research center, pasteur institute of iran, tehran, iran behrouz vaziri department of medical biotechnology, biotechnology research center, pasteur institute of iran, tehran, iran farzaneh barkhordari department of medical biotechnology, biotechnology research center, pasteur institute of iran, tehran, iran leila nematollahi department of medical biotechnology, biotechnology research center, pasteur institute of iran, tehran, iran ahmad adeli department of medical biotechnology, biotechnology research center, pasteur institute of iran, tehran, iran fereidoun mahboudi department of medical biotechnology, biotechnology research center, pasteur institute of iran, tehran, iran

هدف: ایجاد رده‏های سلولی دارای بیان بالا یک مرحله محدود کننده اصلی در روند تولید پروتئین‏های نوترکیب دارویی است. در این مطالعه اثر به‏کارگیری ناحیه متصل شونده به ماتریکس ژن اینترفرون بتای انسانی به‏همراه روش فعال‏سازی راه‏انداز از طریق پروتئین e1a 13s بر بیان فاکتور فعال کننده پلاسمینوژن بافتی (t-pa) در سلول‏های تخمدان هامستر چینی بررسی شده است. مواد و روش‏ها: ناحیه متصل شونده به ماتریکس در سمت...

2005
ROBERT B. COREY

I de Stevens, G., and Nord, F. F., J. Am. Chem. Soc., 75, in press (1953). 10 Brauns, F. E., Ibid., 61, 2120 (1939). 11 (a) Schubert, W. J., and Nord, F. F., Ibid., 72, 977 (1950); (b) Kudzin, S. F., and Nord, F. F., Ibid., 73, 4619 (1951). 12 Nord, F. F., and de Stevens, G., Naturwiss., 39, 479 (1952). '3 Maule, C., Beitrdge wiss. Bot., 4, 166 (1900). 14 Kudzin, S. F., and Nord, F. F., J. Am. ...

2017
Han-Sen Chen Su-Hua Qi Jian-Gang Shen

Tissue plasminogen activator (t-PA) is the only FDA-approved drug for acute ischemic stroke treatment, but its clinical use is limited due to the narrow therapeutic time window and severe adverse effects, including hemorrhagic transformation (HT) and neurotoxicity. One of the potential resolutions is to use adjunct therapies to reduce the side effects and extend t-PA's therapeutic time...

2016
Karen-Sue B. Carlson Lan Nguyen Kat Schwartz Daniel A. Lawrence Bradford S. Schwartz

Tissue-type plasminogen activator (t-PA), initially characterized for its critical role in fibrinolysis, also has key functions in both physiologic and pathologic processes in the CNS. Neuroserpin (NSP) is a t-PA specific serine protease inhibitor (serpin) found almost exclusively in the CNS that regulates t-PA's proteolytic activity and protects against t-PA mediated seizure propagation and bl...

Journal: :journal of mathematical modeling 2015
hossein kheiri bashir naderi

in this paper, we introduce a new hyperchaotic complex t-system. this system has complex nonlinear behavior which we study its dynamical properties including invariance, equilibria and their stability, lyapunov exponents, bifurcation, chaotic behavior and chaotic attractors as well as necessary conditions for this system to generate chaos. we discuss the synchronization with certain and uncerta...

Journal: :Cancer research 1985
P O'Grady H R Lijnen M J Duffy

Total plasminogen activator (PA) activity, tissue-type PA (t-PA) activity, urokinase-like PA activity, and immunoreactive t-PA were measured in benign breast tumors (fibroadenomas), primary breast carcinomas, axillary node metastases, and chest wall recurrences. Total PA activity did not differ significantly in the different types of tumors. However, benign tumors contained predominantly t-PA a...

Background: The human T-cell lymphotropic virus type I is the first retrovirus idenfied in humans. The virus has been associated with adult T-cell leukemia/lymphoma, human T-lymphotropic virus type I, myelopathy/tropical spasc paraparesis, uveis, arthris, pulmonary lymphocyc alveolis, keratoconjuncvis sicca, and infecous dermas. Human T-lymphotropic virus type Iis endemic in Japan...

2003
Wayne L. Chandler Wayne C. Levy Richard C. Veith Stratton

A computer simulation of the circulatory system was used to kinetically model secretion, inhibition, and clearance of tissue plasminogen activator (t-PA) during three different processes that increase active t-PA levels: epinephrine infusion, exercise, and endurance training. Infusion of epinephrine stimulated an increase in t-PA secretion that was proportional to the plasma epinephrine concent...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید